Hans Roland LÖNN;Robert Anthony NIXON;Per Thomas KLINGSTEDT;Robert ZUBAN;Andrew James WATTS;Lars-Erik BRIGGNER;Marie-Lyne ALCARAZ
发明人:
Lars-Erik BRIGGNER,Per Thomas KLINGSTEDT,Hans Roland LÖNN,Robert ZUBAN,Marie-Lyne ALCARAZ,Robert Anthony NIXON,Andrew James WATTS
申请号：
US13534687
公开号：
US20120269872A1
申请日:
2012.06.27
申请国别(地区):
US
年份:
2012
代理人:
摘要：
6-M ethyl-5-(1-methyl-1H-pyrazol-5-yl)-N-{[5-(methylsulfonyl)pyridin-2-yl]methyl}-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2-dihydropyridine-3-carboxamide 4-methylbenzenesulfonate and a novel crystalline form thereof are disclosed together with processes for preparing such salt and form, pharmaceutical compositions comprising such a salt and form, and the methods of treatment using such a salt and form.
